Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

Brent R. L. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation. Birth Defects Res. A Clin. Mol. Teratol., 2005; 73:906–918.

Brezina P. R., et al. The impact of luteal phase support on endometrial estrogen and progesterone receptor expression: a randomized control trial. Reprod. Biol. Endocrinol., 2012; 10:16.

Briggs M. H. Hypospadias, androgen biosynthesis, and synthetic progestogens during pregnancy. Int. J. Fertil., 1982; 27:70–72.

Brincat M., et al. Subcutaneous hormone implants for the control of climacteric symptoms. A prospective study. Lancet, 1984; 1:16–18.

Brinton R. D., et al. Progesterone receptors: form and function in brain. Front Neuroendocrinol, 2008; 29:313–339.

Britt K., Ashworth A., Smalley M.: Pregnancy and the risk of breast cancer. Endocr. Relat. Cancer, 2007; 14 (4):907–933.

Broekmans F. J. M., et al. The antral follicle count: practical recommendations for better standardization. Fertil. Steril., 2010; 94:1044–1051.

Brosens J. J., et al. Steroid receptor action. Best Practice and Research in Clinical Obstetrics and Gynecology, 2004; 18:265–283.

Brosens J. J., et al. A role for menstruation in preconditioning the uterus for successful pregnancy. Am. J. Obstet. Gynecol., 2009b; 200:615:e611–616.

Brosens J. J., et al. Proteomic analysis of endometrium from fertile and infertile patients suggests a role for apolipoprotein A-I in embryo implantation failure and endometriosis. Mol. Human. Reproduc., 2009a; 16:273–285.

Brosens J. J., et al. Steroid receptor action. Best practice and research clinical obstetrics and gynecology, 2004; 18:265–283.

Brosens J. J., Gellersen B. Death or survival — progesterone-dependent cell fate decisions in the human endometrial stroma. J. Mol. Endocrinol., 2006; 36:389–398.

Brosens J. J., Hayashi N., White J. O. Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinol., 1999; 140:4809–4820.

Brosens J. J., Pijnenborg R., Brosens I. A. The myometrial junctional zone spiral arteries in normal and abnormal pregnancies: a review of the literature. Am. J. Obstet, Gynecol., 2002; 187:1416–1423.

Brown A. J., et al. Progestin intrauterine device in an adolescent with grade 2 endometrial cancer. Obstet. Gynecol., 2012; 119 (2 Pt 2):423–426.

Buhrdel P., Willgerodt H., Theile H. Gestation time prolonging effect of progesterone and various synthetic gestagens in the rat]. Acta Biol. Med. Ger., 1974; 32:193–198.

Bulletti C., et al. Uterine contractility during the menstrual cycle. Hum. Reprod., 2000; 15:81–89.

Bulun S., et al. Progesterone resistance in endometriosis: Link to failure to metabolize estradiol. Mol. Cell. Endocrinol., 2006 248:94–103.

Bulun S. E. Endometriosis. New England Journal of Medicine, 2009; 360:268–279.

Burger H. G., et al. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project. Hum. Reprod. Update, 2007; 13:559–565.

Burkman L. J. Characterization of hyperactivated motility by human spermatozoa during capacitation: comparison of fertile and oligozoospermic sperm populations. Arch. Androl. 1984; 13:153–165.

Burney R. O., et al. Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis. Endocrinol., 2007; 148:3814–3826.

Burstein R., Wasserman H. C. The effect of provera on the fetus. Obstet. Gynecol., 1964; 23:931–934.

Busacca M., Vignali M. Endometrioma Excision and Ovarian Reserve: A Dangerous Relation. Journal of Minimally Invasive Gynecology, 2009; 16:142–148.

Butenandt A., Westphal U. Zur Isolierung und Charakterisierung des Corpus luteum Hormons. Berichte Deu0tsche chemische Gesellschaft, 1934; 67 (8):1440–1442.

Buvat J., et al. Luteal support after luteinizing hormone releasing hormone agonist for in vitro fertilization; superiority of human chorionic gonadotropin over oral progesterone. Fertil. Steril., 1990; 53:490–494.

Calaf G. M. Susceptibility of human breast epithelial cells in vitro to hormones and drugs. International. J. Oncol., 2006; 28:285–295.

Calzolari E., et al.Aetiological factors in hypospadias. J. Med. Genet., 1986; 23:333–337.

Cameron I. T., Irvine G., Norman J. E. Menstruation. In Scientific essentials of reproductive Medicine, Eds SG Hiller, HC Kitchener and JP Neilson. London: W.B.Saunders, 1996.

Campagnoli C., et al. Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J. Steroid. Biochem. Mol. Biol., 2005; 96:95–108.

Canfield R. E., et al. Development of an assay for a biomarker of pregnancy and early fetal loss. Environ Health Perspec, 1987; 74:57–66.

Canonico M., et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens. Circulation, 2007; 115 (7):840–5.